{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:52:55Z","timestamp":1791413575697,"version":"4.3.3"},"reference-count":75,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T00:00:00Z","timestamp":1600473600000},"content-version":"vor","delay-in-days":2394,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1074\/jbc.m113.533232","type":"journal-article","created":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T03:24:58Z","timestamp":1389842698000},"page":"6551-6564","source":"Crossref","is-referenced-by-count":52,"title":["Lysophosphatidic Acid Receptor Type 1 (LPA1) Plays a Functional Role in Osteoclast Differentiation and Bone Resorption Activity"],"prefix":"10.1016","volume":"289","author":[{"given":"Marion","family":"David","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Machuca-Gayet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Kikuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Ottewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuka","family":"Mima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Bonnelye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingunn","family":"Holen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f9ben Lopez","family":"Vales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Jurdic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerold","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Cl\u00e9zardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Peyruchaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M113.533232_bib1","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"key":"10.1074\/jbc.M113.533232_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-bioeng-070909-105302","article-title":"Osteocyte mechanobiology and pericellular mechanics","volume":"12","author":"Jacobs","year":"2010","journal-title":"Annu. Rev. Biomed. Eng"},{"key":"10.1074\/jbc.M113.533232_bib3","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.tem.2012.05.005","article-title":"New insights into osteoclastogenic signaling mechanisms","volume":"23","author":"Nakashima","year":"2012","journal-title":"Trends Endocrinol. Metab"},{"key":"10.1074\/jbc.M113.533232_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s007740170042","article-title":"Central control of bone formation","volume":"19","author":"Takeda","year":"2001","journal-title":"J. Bone Miner. Metab"},{"key":"10.1074\/jbc.M113.533232_bib5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","article-title":"Estrogen prevents bone loss via estrogen receptor \u03b1 and induction of Fas ligand in osteoclasts","volume":"130","author":"Nakamura","year":"2007","journal-title":"Cell"},{"key":"10.1074\/jbc.M113.533232_bib6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10555-011-9319-7","article-title":"Autotaxin and LPA receptor signaling in cancer","volume":"30","author":"Houben","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"10.1074\/jbc.M113.533232_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.prostaglandins.2011.05.003","article-title":"Lysophosphatidic acid and calcitriol co-operate to promote human osteoblastogenesis: requirement of albumin-bound LPA","volume":"95","author":"Mansell","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1074\/jbc.M113.533232_bib8","doi-asserted-by":"crossref","first-page":"25792","DOI":"10.1074\/jbc.M110.109322","article-title":"Lysophosphatidic acid signals through multiple receptors in osteoclasts to elevate cytosolic calcium concentration, evoke retraction, and promote cell survival","volume":"285","author":"Lapierre","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.533232_bib9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbrc.2007.03.121","article-title":"Lysophosphatidic acid induces osteocyte dendrite outgrowth","volume":"357","author":"Karagiosis","year":"2007","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.M113.533232_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2000.tb06532.x","article-title":"Development of our current understanding of bioactive lysophospholipids","volume":"905","author":"Moolenaar","year":"2000","journal-title":"Ann. N.Y. Acad. Sci"},{"key":"10.1074\/jbc.M113.533232_bib11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1042\/bj2910677","article-title":"The bioactive phospholipid lysophosphatidic acid is released from activated platelets","volume":"291","author":"Eichholtz","year":"1993","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.M113.533232_bib12","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1172\/JCI200422123","article-title":"Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer","volume":"114","author":"Boucharaba","year":"2004","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.M113.533232_bib13","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1083\/jcb.200708037","article-title":"P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis","volume":"181","author":"Panupinthu","year":"2008","journal-title":"J. Cell Biol"},{"key":"10.1074\/jbc.M113.533232_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.pharmtox.010909.105753","article-title":"LPA receptors: subtypes and biological actions","volume":"50","author":"Choi","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"key":"10.1074\/jbc.M113.533232_bib15","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1476-5381.2011.01622.x","article-title":"Insights into the pharmacological relevance of lysophospholipid receptors","volume":"165","author":"Mutoh","year":"2012","journal-title":"Br. J. Pharmacol"},{"key":"10.1074\/jbc.M113.533232_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.coph.2008.11.010","article-title":"Lysophosphatidic acid (LPA) and its receptors","volume":"9","author":"Noguchi","year":"2009","journal-title":"Curr. Opin. Pharmacol"},{"key":"10.1074\/jbc.M113.533232_bib17","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ijc.25341","article-title":"Lysophosphatidic acid-induced expression of periostin in stromal cells: Prognostic relevance of periostin expression in epithelial ovarian cancer","volume":"128","author":"Choi","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1074\/jbc.M113.533232_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbalip.2012.08.001","article-title":"Lysophosphatidic acid: A potential mediator of osteoblast-osteoclast signaling in bone","volume":"1831","author":"Sims","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M113.533232_bib19","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.1073\/pnas.97.24.13384","article-title":"Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior","volume":"97","author":"Contos","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.533232_bib20","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1083\/jcb.135.4.1071","article-title":"Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex","volume":"135","author":"Hecht","year":"1996","journal-title":"J. Cell Biol"},{"key":"10.1074\/jbc.M113.533232_bib21","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/nn1157","article-title":"Non-proliferative effects of lysophosphatidic acid enhance cortical growth and folding","volume":"6","author":"Kingsbury","year":"2003","journal-title":"Nat. Neurosci"},{"key":"10.1074\/jbc.M113.533232_bib22","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nm1060","article-title":"Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling","volume":"10","author":"Inoue","year":"2004","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.M113.533232_bib23","doi-asserted-by":"crossref","first-page":"99ra87","DOI":"10.1126\/scitranslmed.3002095","article-title":"Lysophosphatidic acid signaling may initiate fetal hydrocephalus","volume":"3","author":"Yung","year":"2011","journal-title":"Sci. Transl. Med"},{"key":"10.1074\/jbc.M113.533232_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nm1685","article-title":"The lysophosphatidic acid receptor LPA(1) links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak","volume":"14","author":"Tager","year":"2008","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.M113.533232_bib25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2009.09.055","article-title":"Lysophosphatidic acid stimulates the intestinal brush border Na+\/H+ exchanger 3 and fluid absorption via LPA(5) and NHERF2","volume":"138","author":"Lin","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1074\/jbc.M113.533232_bib26","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/CIRCRESAHA.108.180778","article-title":"Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure","volume":"103","author":"Panchatcharam","year":"2008","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.M113.533232_bib27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF03185929","article-title":"Altered food consumption in mice lacking lysophosphatidic acid receptor-1","volume":"65","author":"Dusaulcy","year":"2009","journal-title":"J. Physiol. Biochem"},{"key":"10.1074\/jbc.M113.533232_bib28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bone.2011.04.018","article-title":"Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass","volume":"49","author":"Gennero","year":"2011","journal-title":"Bone"},{"key":"10.1074\/jbc.M113.533232_bib29","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.1128\/MCB.22.19.6921-6929.2002","article-title":"Characterization of lpa(2) (Edg4) and lpa(1)\/lpa(2) (Edg2\/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2)","volume":"22","author":"Contos","year":"2002","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.M113.533232_bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature03505","article-title":"LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing","volume":"435","author":"Ye","year":"2005","journal-title":"Nature"},{"key":"10.1074\/jbc.M113.533232_bib31","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1095\/biolreprod.108.068783","article-title":"Age-dependent loss of sperm production in mice via impaired lysophosphatidic acid signaling","volume":"79","author":"Ye","year":"2008","journal-title":"Biol. Reprod"},{"key":"10.1074\/jbc.M113.533232_bib32","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1182\/blood-2010-03-272443","article-title":"LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis","volume":"116","author":"Sumida","year":"2010","journal-title":"Blood"},{"key":"10.1074\/jbc.M113.533232_bib33","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/jcb.22471","article-title":"LPA induces osteoblast differentiation through interplay of two receptors: LPA1 and LPA4","volume":"109","author":"Liu","year":"2010","journal-title":"J. Cell. Biochem"},{"key":"10.1074\/jbc.M113.533232_bib34","doi-asserted-by":"crossref","first-page":"17608","DOI":"10.1074\/jbc.M111.330183","article-title":"Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain","volume":"287","author":"Lin","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.533232_bib35","doi-asserted-by":"crossref","first-page":"7906","DOI":"10.1074\/jbc.273.14.7906","article-title":"Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid","volume":"273","author":"An","year":"1998","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.533232_bib36","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1124\/mol.60.6.1173","article-title":"Activity of 2-substituted lysophosphatidic acid (LPA) analogs at LPA receptors: discovery of a LPA1\/LPA3 receptor antagonist","volume":"60","author":"Heise","year":"2001","journal-title":"Mol. Pharmacol"},{"key":"10.1074\/jbc.M113.533232_bib37","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1124\/mol.64.4.994","article-title":"Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors","volume":"64","author":"Ohta","year":"2003","journal-title":"Mol. Pharmacol"},{"key":"10.1074\/jbc.M113.533232_bib38","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3892\/ijo.2011.1309","article-title":"Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis","volume":"40","author":"David","year":"2012","journal-title":"Int. J. Oncol"},{"key":"10.1074\/jbc.M113.533232_bib39","doi-asserted-by":"crossref","first-page":"23589","DOI":"10.1074\/jbc.M603670200","article-title":"GPR92 as a new G12\/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5","volume":"281","author":"Lee","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.533232_bib40","doi-asserted-by":"crossref","first-page":"17731","DOI":"10.1074\/jbc.M808506200","article-title":"Identification and characterization of a novel lysophosphatidic acid receptor, p2y5\/LPA6","volume":"284","author":"Yanagida","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.533232_bib41","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1128\/MCB.20.11.4106-4114.2000","article-title":"Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion","volume":"20","author":"Jung","year":"2000","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.M113.533232_bib42","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature07713","article-title":"Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis","volume":"458","author":"Ishii","year":"2009","journal-title":"Nature"},{"key":"10.1074\/jbc.M113.533232_bib43","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc"},{"key":"10.1074\/jbc.M113.533232_bib44","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrg1122","article-title":"Genetic regulation of osteoclast development and function","volume":"4","author":"Teitelbaum","year":"2003","journal-title":"Nat. Rev. Genet"},{"key":"10.1074\/jbc.M113.533232_bib45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1189\/jlb.0107051","article-title":"G-protein-coupled receptor expression, function, and signaling in macrophages","volume":"82","author":"Lattin","year":"2007","journal-title":"J. Leukocyte Biol"},{"key":"10.1074\/jbc.M113.533232_bib46","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0898-6568(02)00117-1","article-title":"Activation of human monocytic cells by lysophosphatidic acid and sphingosine-1-phosphate","volume":"15","author":"Fueller","year":"2003","journal-title":"Cell. Signal"},{"key":"10.1074\/jbc.M113.533232_bib47","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbalip.2004.03.002","article-title":"Expression of the lysophospholipid receptor family and investigation of lysophospholipid-mediated responses in human macrophages","volume":"1682","author":"Duong","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M113.533232_bib48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejcb.2005.09.008","article-title":"Podosome and sealing zone: specificity of the osteoclast model","volume":"85","author":"Jurdic","year":"2006","journal-title":"Eur. J. Cell Biol"},{"key":"10.1074\/jbc.M113.533232_bib49","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1091\/mbc.8.8.1415","article-title":"Lysophosphatidic acid and microtubule-destabilizing agents stimulate fibronectin matrix assembly through Rho-dependent actin stress fiber formation and cell contraction","volume":"8","author":"Zhang","year":"1997","journal-title":"Mol. Biol. Cell"},{"key":"10.1074\/jbc.M113.533232_bib50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0169-6009(91)90124-I","article-title":"The ovariectomized rat model of postmenopausal bone loss","volume":"15","author":"Kalu","year":"1991","journal-title":"Bone Miner"},{"key":"10.1074\/jbc.M113.533232_bib51","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00223-007-9091-4","article-title":"Secreted tartrate-resistant acid phosphatase 5b is a marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model","volume":"82","author":"Rissanen","year":"2008","journal-title":"Calcif. Tissue Int"},{"key":"10.1074\/jbc.M113.533232_bib52","doi-asserted-by":"crossref","first-page":"e9741","DOI":"10.1371\/journal.pone.0009741","article-title":"Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts","volume":"5","author":"David","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.M113.533232_bib53","doi-asserted-by":"crossref","first-page":"26641","DOI":"10.1074\/jbc.M110.119909","article-title":"c-Src-mediated phosphorylation of thyroid hormone receptor-interacting protein 6 (TRIP6) promotes osteoclast sealing zone formation","volume":"285","author":"McMichael","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.533232_bib54","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ejcb.2008.03.002","article-title":"Rho GTPases in osteoclasts: orchestrators of podosome arrangement","volume":"87","author":"Ory","year":"2008","journal-title":"Eur. J. Cell Biol"},{"key":"10.1074\/jbc.M113.533232_bib55","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1073\/pnas.95.11.6151","article-title":"A single receptor encoded by vzg-1\/lpA1\/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid","volume":"95","author":"Fukushima","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.533232_bib56","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0955-0674(97)80059-2","article-title":"Lysophosphatidic acid: G-protein signalling and cellular responses","volume":"9","author":"Moolenaar","year":"1997","journal-title":"Curr. Opin. Cell Biol"},{"key":"10.1074\/jbc.M113.533232_bib57","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/jnci\/djn378","article-title":"Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells","volume":"100","author":"Yu","year":"2008","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1074\/jbc.M113.533232_bib58","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1388-1981(02)00180-4","article-title":"Mitogenic action of LPA in prostate","volume":"1582","author":"Daaka","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M113.533232_bib59","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3727\/096504009790217399","article-title":"Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms","volume":"18","author":"Boucharaba","year":"2009","journal-title":"Oncol. Res"},{"key":"10.1074\/jbc.M113.533232_bib60","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1096\/fj.12-219378","article-title":"LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation","volume":"27","author":"Sakai","year":"2013","journal-title":"FASEB J"},{"key":"10.1074\/jbc.M113.533232_bib61","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nri2062","article-title":"Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems","volume":"7","author":"Takayanagi","year":"2007","journal-title":"Nat. Rev. Immunol"},{"key":"10.1074\/jbc.M113.533232_bib62","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1172\/JCI200316924","article-title":"c-Fms and the \u03b1v\u03b23 integrin collaborate during osteoclast differentiation","volume":"111","author":"Faccio","year":"2003","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.M113.533232_bib63","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.1038\/sj.onc.1203121","article-title":"Expression of the SRF gene occurs through a Ras\/Sp\/SRF-mediated-mechanism in response to serum growth signals","volume":"18","author":"Spencer","year":"1999","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M113.533232_bib64","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.prostaglandins.2009.02.002","article-title":"Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance","volume":"91","author":"Lin","year":"2010","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1074\/jbc.M113.533232_bib65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbalip.2012.06.004","article-title":"Pleiotropic activity of lysophosphatidic acid in bone metastasis","volume":"1831","author":"Peyruchaud","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M113.533232_bib66","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/bbrc.1999.1958","article-title":"Solution structures of human parathyroid hormone fragments hPTH(1\u201334) and hPTH(1\u201339) and bovine parathyroid hormone fragment bPTH(1\u201337)","volume":"267","author":"Marx","year":"2000","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.M113.533232_bib67","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1210\/jc.2012-2142","article-title":"Parathyroid hormone-related protein: an update","volume":"97","author":"Wysolmerski","year":"2012","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1074\/jbc.M113.533232_bib68","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/8756-3282(95)00113-R","article-title":"The anabolic effect of human PTH(1\u201334) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate\u2013is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system?","volume":"16","author":"Delmas","year":"1995","journal-title":"Bone"},{"key":"10.1074\/jbc.M113.533232_bib69","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1210\/en.2004-1282","article-title":"Bone response to intermittent parathyroid hormone is altered in mice null for \u03b2-arrestin2","volume":"146","author":"Ferrari","year":"2005","journal-title":"Endocrinology"},{"key":"10.1074\/jbc.M113.533232_bib70","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jcb.20438","article-title":"Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: an analysis by DNA microarray","volume":"95","author":"Onyia","year":"2005","journal-title":"J. Cell. Biochem"},{"key":"10.1074\/jbc.M113.533232_bib71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1749-6632.2010.05766.x","article-title":"The use of bisphosphonates in cancer treatment","volume":"1218","author":"Coleman","year":"2011","journal-title":"Ann. N.Y. Acad. Sci"},{"key":"10.1074\/jbc.M113.533232_bib72","doi-asserted-by":"crossref","first-page":"9643","DOI":"10.1073\/pnas.0600979103","article-title":"The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases","volume":"103","author":"Boucharaba","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.533232_bib73","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2174\/1381612033453640","article-title":"New insights into the molecular mechanisms of action of bisphosphonates","volume":"9","author":"Rogers","year":"2003","journal-title":"Curr. Pharm. Des"},{"key":"10.1074\/jbc.M113.533232_bib74","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.prostaglandins.2006.04.001","article-title":"Lysophosphatidic acid cooperates with 1\u03b1,25(OH)2D3 in stimulating human MG63 osteoblast maturation","volume":"80","author":"Gidley","year":"2006","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1074\/jbc.M113.533232_bib75","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/art.37991","article-title":"Necessity of lysophosphatidic acid receptor 1 for development of arthritis","volume":"65","author":"Miyabe","year":"2013","journal-title":"Arthritis Rheum"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820444758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820444758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M113.533232","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T05:54:47Z","timestamp":1716443687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820444758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":75,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0021925820444758"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m113.533232","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}